- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03654807
The Effect of Walking on Frailty
August 20, 2024 updated by: Margaret Danilovich, Northwestern University
The Effect of High Intensity Walking on Frailty
The purpose of this study is to test the effect of walking intensity on both frailty category (i.e., frail, pre-frail, and nonfrail) and frailty score as a continuous outcome on the SHARE-FI (frailty instrument).
As well as test the effect of walking intensity on mobility, physical function, balance, and total Physical Activity.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Frailty impacts up to 60% of older adults and is a leading cause of dependency among older adults.
Frail older adults experience physical problems such as balance difficulties, weakness, decreased endurance, and reduced walking speed that increase risk for falls, hospitalizations, institutionalization, and death.
Physical activity has multi-system health benefits and is the most recommended frailty management intervention, but guidelines regarding the specific intensity of physical activity remain unclear.
High intensity physical activity is an established and safe therapeutic approach in other populations, but it is unclear as to the extent to which high intensity activity can reduce or reverse frailty.
This cluster-randomized study will compare a high intensity walking (HIW) intervention to a self-selected, casual speed walking (CSW) intervention implemented within retirement communities for pre-frail and frail older adults.
Investigators will randomize 10 retirement communities with 20 participants at each site (200 total participants) to either a 4-month HIW or CSW intervention.
All participants will receive 48, individually supervised overground walking sessions occurring within their retirement community.
At the beginning and end of the study, investigators will measure participants' frailty, mobility, physical functioning, balance, and total physical activity measured via an ActivPal accelerometer worn for a 1-week observation period to compare which treatment strategy, HIW or CSW, worked better to reduce frailty (aim #1).
Investigators will use the SHARE-Frailty Instrument to evaluate frailty as both a categorical (e.g.
non-frail, pre-frail, or frail) and a continuous outcome.
This approach will allow investigators to determine how participants move between frailty categories as well as within frailty categories in response to intervention.
In aim #2, investigators will determine the effect of walking intensity on mobility, physical functioning, balance, and total physical activity.
Investigators hypothesize that HIW participants will show decreased frailty and improved mobility, physical functioning, balance, and physical activity at 4 months.
Currently, the optimal physical activity guidelines for older adults with frailty are uncertain.
Results from this study will provide important knowledge to inform activity guidelines for older adults with frailty and information on a transformative approach to reducing frailty, improving function, and increasing physical activity among a growing segment of the older adults population.
Study Type
Interventional
Enrollment (Actual)
156
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern Univiersity Department of Physical Therapy and Human Movement Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
• > 60 years of age with pre-frailty or frailty as determined on the SHARE-FI.
- Able to ambulate at least 10 feet with moderate assistance (<50% physical assistance) or less. Participants will be able to use their assistive device (e.g. cane or walker) during sessions.
- Resident of one of the 10 enrolled retirement community locations. Individuals must be > 60 years of age to move into the retirement communities by virtue of the individual community policies.
- Provision of informed consent and clearance for participation as determined by the Exercise and Screening for You (EASY).
Exclusion Criteria:
• Uncontrolled cardiovascular, metabolic, renal, or respiratory disease that limits exercise participation (e.g., previous heart attack within 3 months of enrollment or uncontrolled diabetes)
- Resting blood pressure > 180/110 mmHg.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: High Intensity Walking
HIW (70-80% HRmax)
|
70-80% HRmax
|
|
Experimental: Casual Speed Walking
Self selected pace
|
Self selected pace
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in frailty as measured by the Survey of Health, Ageing, and Retirement in Europe-Frailty Instrument (SHARE-FI)
Time Frame: Baseline and four months
|
SHARE-FI which assesses fatigue, appetite, weakness, walking difficulties, and low physical activity
|
Baseline and four months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Improved mobility as measured by gait speed
Time Frame: Baseline and four months
|
Measures related to overall health and mobility
|
Baseline and four months
|
|
Improved physical function on the Short Physical Performance Battery
Time Frame: Baseline and four months
|
Provide an overall assessment of functional status and physical performance
|
Baseline and four months
|
|
Improved balance as measured by the Berg Balance Scale
Time Frame: Baseline and four months
|
The Berg Balance Scale is a valid and reliable 14 item tool to evaluate static and dynamic balance among older adults.
Minimum Score 0 to Maximum Score 56.
• Score of < 45 indicates individuals may be at greater risk of falling
|
Baseline and four months
|
|
Total daily physical activity
Time Frame: Baseline and Four Months
|
ActivPal Activity Monitors worn for a one week ambulatory monitoring period, data are sampled at 20 Hz in 10 second intervals.
|
Baseline and Four Months
|
|
Improved mobility as measured by Time Up and Go
Time Frame: Baseline and Four Months
|
Measures related to mobility
|
Baseline and Four Months
|
|
Improved mobility as measured by 6 Minute Walk Test
Time Frame: Baseline and Four Months
|
Measures related to mobility
|
Baseline and Four Months
|
|
Improved balance as measured by the Falls Efficacy
Time Frame: Baseline and Four Months
|
Falls Efficacy Scale as this is a widely-used measure among older adults that evaluates the fear of falling and balance confidence, 10-item questionnaire with scores ranging from minimum score 0 to maximum score 100.
A total score of greater than 70 indicates that the person has a fear of falling
|
Baseline and Four Months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Margaret Danilovich, PhD, Northwestern University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 26, 2018
Primary Completion (Actual)
January 31, 2023
Study Completion (Actual)
May 31, 2024
Study Registration Dates
First Submitted
August 21, 2018
First Submitted That Met QC Criteria
August 29, 2018
First Posted (Actual)
August 31, 2018
Study Record Updates
Last Update Posted (Actual)
August 22, 2024
Last Update Submitted That Met QC Criteria
August 20, 2024
Last Verified
August 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU00207757
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Frailty
-
University of PennsylvaniaCompleted
-
McMaster UniversityRecruitingFrailty | Frailty Syndrome | Frail Older Adults | Frailty in AgingCanada
-
Universidad Francisco de VitoriaNot yet recruitingFrailty Syndrome | Respiratory Muscle Weakness | Age-Related Frailty | Geriatric Health
-
Universidad Francisco de VitoriaActive, not recruitingFrailty Syndrome | Respiratory Muscle Weakness | Age-Related Frailty | Geriatric HealthSpain
-
University of IcelandLandspitali University HospitalRecruitingFrailty Syndrome | Elective Surgery | Frailty in Adult SurgeryIceland
-
University of NottinghamRecruitingFrailty | Diet | Systemic Inflammatory Response | Dietary Fiber | Frailty at Older Adults | Pre-FrailtyUnited Kingdom
-
Maximilian KönigNot yet recruiting
-
Instituto Tecnologico y de Estudios Superiores...Not yet recruiting
-
Xijing HospitalEnrolling by invitationFrailty SyndromeChina
-
Longeveron Inc.CompletedAging FrailtyUnited States
Clinical Trials on High Intensity Walking
-
University of ChicagoTerminatedFrailtyUnited States
-
Texas Woman's UniversityTexas Health ResourcesCompletedHeart Failure NYHA Class II | Heart Failure NYHA Class IIIUnited States
-
University of VirginiaCompletedCardiovascular Diseases | Breast Cancer | CardiotoxicityUnited States
-
The University of Hong KongCompletedMild Cognitive ImpairmentHong Kong
-
University of AlbertaAlberta Paraplegic foundationNot yet recruitingSpinal Cord Injuries (SCI)
-
Ottawa Heart Institute Research CorporationActive, not recruitingCoronary Artery DiseaseCanada
-
Cairo UniversityRecruiting
-
Ottawa Heart Institute Research CorporationOntario Ministry of Health and Long Term Care; Heart and Stroke Foundation...CompletedCoronary Artery Disease (CAD)Canada